Revolution Medicines, Inc. (RVMD) Misses Q4 EPS by 28c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q4 EPS of ($1.86), $0.28 worse than the analyst estimate of ($1.58).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• DoJ antitrust division was instructed earlier this week to pause all work with the Canadian government - WSJ
• US energy rig count holds steady for second week, Baker Hughes says